MSFT
Near-Term Correction: As you mentioned, there appears to be a divergence between the price action and technical indicators like MACD and RSI, suggesting that the upward momentum may be fading, and a price correction is likely.
Descending Trend: Based on your observation, the stock is currently in a descending trend on the daily timeframe, with peaks at $414.85 in September and $438.5 in October, indicating a potential test of support levels soon.
Stop Loss Level: $442 is the suggested stop-loss level based on your analysis. If the stock moves above this level, it could signal that the corrective move might be invalidated temporarily.
Target Price: Your target range is $350 - $347.5, which represents the potential support levels in case of a correction.
Recommendations:
Reduce Positions: If you hold MSFT stock, it may be a good idea to lighten your position or exit temporarily until the correction completes, especially if you're not comfortable with the potential risks.
Monitor Technical Indicators: It’s important to keep an eye on MACD and RSI on shorter intervals (daily or even hourly) to confirm if the
Descending Trend: Based on your observation, the stock is currently in a descending trend on the daily timeframe, with peaks at $414.85 in September and $438.5 in October, indicating a potential test of support levels soon.
Stop Loss Level: $442 is the suggested stop-loss level based on your analysis. If the stock moves above this level, it could signal that the corrective move might be invalidated temporarily.
Target Price: Your target range is $350 - $347.5, which represents the potential support levels in case of a correction.
Recommendations:
Reduce Positions: If you hold MSFT stock, it may be a good idea to lighten your position or exit temporarily until the correction completes, especially if you're not comfortable with the potential risks.
Monitor Technical Indicators: It’s important to keep an eye on MACD and RSI on shorter intervals (daily or even hourly) to confirm if the
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.